Junfang Zheng

capital medical university

H指数:23

被引数:1,152

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

KAT8-mediated MDH2 lactylation promotes renal cancer progression by enhancing mitochondrial function and stress resistance

KAT8介导的MDH2乳酰化通过增强线粒体功能和应激抵抗促进肾癌进展

International Journal of Biological Macromolecules

IF8.5

2025-08-050

PRE

YTHDC1 lactylation regulates its phase separation to enhance target mRNA stability and promote RCC progression

YTHDC1的乳酰化调控其相分离以增强靶mRNA稳定性并促进RCC进展

Molecular Cell

IF16.6

2025-07-170

PRE

PDZK1 suppresses TNBC development and sensitizes TNBC cells to erlotinib via the EGFR pathway

CELL DEATH & DISEASE

IF9.6

2024-04-122

OAAI

PDZK1 sensitizes TNBC cells to erlotinib via promoting c-Cbl-mediated EGFR degradation and inhibiting EGFR phosphorylation

CANCER RESEARCH

IF16.6

2024-03-220

PRE

GLUD1 suppresses renal tumorigenesis and development via inhibiting PI3K/Akt/mTOR pathway

FRONTIERS IN ONCOLOGY

IF3.3

2022-09-2010

OAAI

Bioactive peptide apelin rescues acute kidney injury by protecting the function of renal tubular mitochondria

AMINO ACIDS

IF2.4

2021-07-1216

PREAI

SDHB Suppresses the Tumorigenesis and Development of ccRCC by Inhibiting Glycolysis

FRONTIERS IN ONCOLOGY

IF3.3

2021-05-1930

OAAI

iTRAQ-facilitated proteomic analysis of Bacillus cereus via degradation of malachite green

JOURNAL OF MICROBIOLOGY

IF2.6

2021-02-011

PREAI

CAP70 suppresses the development of triple-negative breast cancer by inhibiting EGFR pathway activation

CANCER RESEARCH

IF16.6

2020-08-150

PRE

Long noncoding RNA PENG upregulates PDZK1 expression by sponging miR-15b to suppress clear cell renal cell carcinoma cell proliferation

ONCOGENE

IF7.3

2020-04-2727

PRE

ECHS1 suppresses renal cell carcinoma development through inhibiting mTOR signaling activation

BIOMEDICINE & PHARMACOTHERAPY

IF7.5

2020-03-0118

OAAI

SIRT5-mediated SDHA desuccinylation promotes clear cell renal cell carcinoma tumorigenesis

SDHA去乙酰化SIRT5-mediated促进肾透明细胞癌的肿瘤发生

FREE RADICAL BIOLOGY AND MEDICINE

IF8.2

2019-04-0177

PREAI

New mechanistic insights of clear cell renal cell carcinoma from integrated miRNA and mRNA expression profiling studies

BIOMEDICINE & PHARMACOTHERAPY

IF7.5

2019-03-0117

OAAI

PDZK1 inhibits the development and progression of renal cell carcinoma by suppression of SHP-1 phosphorylation

ONCOGENE

IF7.3

2017-07-1032

OAAI

NHERF1 inhibits proliferation of triple-negative breast cancer cells by suppressing GPER signaling

NHERF1通过抑制GPER信号抑制三阴性乳腺癌细胞增殖

ONCOLOGY REPORTS

IF3.9

2017-05-1818

OAAI

Low level of PDZ domain containing 1 (PDZK1) predicts poor clinical outcome in patients with clear cell renal cell carcinoma

低水平的PDZ结构域1 (PDZK1) 可预测透明细胞肾细胞癌患者的不良临床预后

EBIOMEDICINE

IF10.8

2017-02-0131

OAAI

Interaction with NHERF1 enhances protein stability of G protein-coupled estrogen receptor

CANCER RESEARCH

IF16.6

2016-07-150

PRE

Ezrin-radixin-moesin-binding phosphoprotein-50 regulates EGF-induced AKT activation through interaction with EGFR and PTEN

ONCOLOGY REPORTS

IF3.9

2015-11-0212

OAAI

NHERF1 regulates actin cytoskeleton organization through modulation of α-actinin-4 stability

NHERF1通过调节 α-肌动蛋白-4稳定性调节肌动蛋白细胞骨架组织

FASEB JOURNAL

IF4.2

2015-10-0230

PREAI

Regulation of β2-adrenergic receptor cell surface expression by interaction with cystic fibrosis transmembrane conductance regulator-associated ligand (CAL)

AMINO ACIDS

IF2.4

2015-04-164

PREAI

Junfang Zheng

个人简介

教育背景

工作经历

荣誉奖项

研究方向